Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.

View in: PubMed

subject areas

Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
B-Lymphocytes
Child
Child, Preschool
Chronic Disease
Combined Modality Therapy
Cytokines
DNA, Viral
Epstein-Barr Virus Infections
Female
Hematopoietic Stem Cell Transplantation
Herpesvirus 4, Human
Humans
Japan
Killer Cells, Natural
Lymphoproliferative Disorders
Male
Middle Aged
Polymerase Chain Reaction
RNA, Viral
Survival Rate
T-Lymphocytes
Treatment Outcome
United States
Young Adult

authors with profiles

Michael R. Bishop